The immunostaining of these pancreatic cancer tissues revealed that Cldn1 was highly expressed in the cytoplasm of some cancer cells and that Cldn1 was associated with a poor differentiation of cancer cells and poor prognosis in patients with PDAC. This evidence concerns the gene CLDN1 and pancreatic neoplasm.